Saturday, November 21st, 2009

Posts Tagged ‘ DNDN ’

How to Profit from Immunotherapy & Regenerative Medicine

Oct 8th, 2009 | By Marc Lichtenfeld | Category: Stock Market Investing

The procedure has been called “one of the most barbaric mistakes ever perpetrated by mainstream medicine.” Back when medicine was highly primitive, the process involved shoving an ice pick-like instrument between the upper eyelid and the eye in hopes of severing certain nerves of the frontal lobe.



The Second Quarter’s Biggest Winners… and Losers

Jul 2nd, 2009 | By Andrew Snyder | Category: Stock Market Investing

The second quarter of 2009 was filled with gains and plenty of plain. After looking at the quarter’s winners and losers, one thing is obvious, biotechs can make or break your portfolio.



Global Investing Roundups Tuesday, October 7th, 2008

Oct 7th, 2008 | By William Patalon III | Category: Financial News, International Investing

S&P Slashes RBS Rating; Dendreon’s Big Boost; Eli Lilly Comes Out Ahead on ImClone; AgFeed’s Hungry For Its Own Shares; Bank of America Surprises with Loss; Paulson Taps Another Goldman Exec.